Filter posts

BIO Investor Forum Closing Plenary: How Fragile is the Biotech Rally After Five Positive Years?

Last week’s 13th Annual BIO Investor Forum closed on Wednesday with a plenary session asking, …

2014 BIO Investor Forum Fireside Chat with Nick Leschly and Chris Collins

Nick Leschly has served as bluebird bio’s president and chief executive officer since September 2010. …

Electroceuticals and Digital Drug Delivery: Neurological Stimulation and Beyond

Some of the most experienced executives in biotechnology have begun asking themselves, “Can we foresee …

Biotech CEOs Talk JOBS Act and IPO Experiences at 2014 BIO Investor Forum

The JOBS Act has contributed to a dramatic acceleration in new biotech IPOs since its …

Tekmira CEO Discusses Ebola Therapy Development at 2014 BIO Investor Forum

Today at the 13th Annual BIO Investor Forum, Tekmira CEO Dr. Mark Murray participated in a …

Fireside Chat with Ken Drazan, MD, Head of Johnson & Johnson Innovation

Day one of the BIO Investor Forum featured a Fireside Chat with Ken Drazan, MD, …

BIO 2015 – Call for Sessions Extended

It’s not too late to submit a session proposal for the 2015 BIO International Convention. …

Biotech CEOs Speak Out on JOBS Act Success

Enacted in April 2012, the Jumpstart Our Business Startups (JOBS) Act makes the pathway to …

Looking Ahead to the 2014 BIO Investor Forum, Biotech IPO Hopefuls Continue to Seek Funding

As mentioned in Fierce Biotech, a new crop of biotech IPO hopefuls have recently thrown their …

The 2014 BIO International Convention Closes in San Diego

The 2014 BIO International Convention, where the global biotech community meets, connecting the people, companies …